BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Liver, Autoimmunity, Rapamycin, rs7903146, PTEN, Angiogenesis, Obesity)
Bookmark Forward

QuickView for Atenolol (compound)


Genetic Markers

Most Correlated Genes

  1. IGFBP5
  2. PPP2CA
  3. ADRB1
  4. Rup2
  5. FOS
Explore Genetic Markers Results

Pathway Enrichment

Most Correlated Biogroups

  1. regulation of cellular component organization
  2. PILON_KLF1_TARGETS_DN
  3. tube development
  4. Predicted Gene Targets for miR-124a
  5. DACOSTA_UV_RESPONSE_VIA_ERCC3_DN
Explore Pathway Enrichment Results

Curated Studies

Most Correlated Studies

  1. Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Codelink]
  2. Drug Matrix In Vivo Toxicogenomic Study - Rat Heart [Affymetrix]
  3. Drug Matrix In Vivo Toxicogenomic Study - Rat Thigh [Affymetrix]
  4. Drug target sets for approved compounds
  5. Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. A synthesis on the sub-lethal toxicity of atenolol, a beta-blocker, in teleost fish.
  2. New spectrophotometric and smartphone-based colorimetric methods for determination of atenolol in ph…
  3. Atenolol-imprinted polymer: a DFT study.
  4. Investigating the biological degradation of the drug β-blocker atenolol from wastewater using the SB…
  5. Novel pathway and acetate-facilitated complete atenolol degradation by Hydrogenophaga sp. YM1 isolat…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions
  2. Study of Atenolol Influence on Blood Pressure During Resistance Exercise
  3. Genetically Determined Response to Atenolol in Patients With Persistent Atrial Fibrillation
  4. The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.
  5. Losartan Versus Atenolol for the Treatment of Marfan Syndrome
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.